TRIM3 and colorectal cancer: As a result, TRIM3 emerges as a promising new target for the treatment of colorectal cancer, given its potential to inhibit invasion and metastasis, induce apoptosis, and regulate essential signaling pathways involved in colorectal cancer progression.